Totus Medicines’ has come out of stealth with a technology that could enable it to treat cancers with known targets but no specific drugs—and it’s going into clinical trials next year.
Totus Medicines’ has come out of stealth with a technology that could enable it to treat cancers with known targets but no specific drugs—and it’s going into clinical trials next year.